Short Interest in Agape ATP Corporation (NASDAQ:ATPC) Decreases By 94.0%

Agape ATP Corporation (NASDAQ:ATPC) saw a large drop in short interest in the month of June. As of June 15th, there was short interest totaling 18,792 shares, a drop of 94.0% from the May 31st total of 314,161 shares. Currently, 1.9% of the company’s shares are sold short. Based on an average daily volume of 804,194 shares, the days-to-cover ratio is currently 0.0 days.

Agape ATP Stock Performance

Agape ATP stock traded up $0.13 during mid-day trading on Friday, reaching $3.13. 91,736 shares of the company were exchanged, compared to its average volume of 4,355,800. The firm has a market cap of $3.13 million, a P/E ratio of -2.35 and a beta of 0.08. The business has a fifty day moving average of $2.90 and a 200 day moving average of $4.28. Agape ATP has a 12-month low of $1.72 and a 12-month high of $75.25.

Agape ATP (NASDAQ:ATPC) last announced its quarterly earnings results on Friday, May 15th. The company reported ($0.33) earnings per share (EPS) for the quarter. The company had revenue of $0.27 million during the quarter. Agape ATP had a negative net margin of 125.89% and a negative return on equity of 8.43%.

Institutional Trading of Agape ATP

A hedge fund recently raised its position in Agape ATP stock. Citadel Advisors LLC increased its position in shares of Agape ATP Corporation (NASDAQ:ATPC) by 95.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 65,130 shares of the company’s stock after acquiring an additional 31,849 shares during the quarter. Citadel Advisors LLC owned about 0.13% of Agape ATP worth $82,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 0.01% of the company’s stock.

Wall Street Analyst Weigh In

ATPC has been the subject of several research reports. Wall Street Zen cut Agape ATP from a “hold” rating to a “sell” rating in a report on Sunday, June 21st. Weiss Ratings restated a “sell (e+)” rating on shares of Agape ATP in a report on Friday, May 22nd. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company currently has a consensus rating of “Sell”.

Agape ATP Company Profile

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.